Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06333899Early Phase 1Recruiting
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Anaplastic AstrocytomaDiffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3K27-altered+6 more
StudychairStart date: 2025-08-03

Research Network

Collaboration Network

11 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Maryam Fouladi, MD

Nationwide Children's Hospital

Very Similar
10 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaHigh Grade GliomaAnaplastic Astrocytoma+6 more

Worked with same sponsors:

Nationwide Children's HospitalPfizer
Collaborated on 1 trial
Similarity Score94%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Anaplastic AstrocytomaDiffuse Intrinsic Pontine GliomaHigh Grade Glioma
Similarity Score10%

John W Glod, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaAnaplastic AstrocytomaHigh Grade Glioma
Similarity Score10%

Jaymes Holland

Alaunos Therapeutics

Related
8 trials

Shared therapeutic areas:

GlioblastomaDiffuse Intrinsic Pontine GliomaGlioblastoma Multiforme
Similarity Score10%

Thomas Kaley, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

GlioblastomaAnaplastic Astrocytoma

Worked with same sponsors:

Pfizer
Similarity Score7%

Katherine E Warren, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Anaplastic AstrocytomaGlioblastoma Multiforme
Similarity Score7%

Kevin A camphausen, M.D.

National Cancer Institute (NCI)

Related
17 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme
Similarity Score7%

Sabine Mueller, MD, PhD, MAS

University of California, San Francisco

Related
10 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaGlioblastoma
Similarity Score7%

Annick Desjardins, MD, FRCPC

Duke University

Related
9 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme
Similarity Score7%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

GlioblastomaGlioblastoma Multiforme
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06333899Early Phase 1StudyChair

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Anaplastic AstrocytomaDiffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3K27-altered+6 more
Recruiting

All 1 trials loaded